These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 29593013

  • 1. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S, Madsen CM, Varbo A, Benn M, Nordestgaard BG.
    Circulation; 2018 Aug 07; 138(6):578-589. PubMed ID: 29593013
    [Abstract] [Full Text] [Related]

  • 2. Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
    Eyrich TM, Dalila N, Christoffersen M, Tybjærg-Hansen A, Stender S.
    Atherosclerosis; 2024 Oct 07; 397():118574. PubMed ID: 39244851
    [Abstract] [Full Text] [Related]

  • 3. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
    Beheshti S, Madsen CM, Varbo A, Nordestgaard BG.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2657-2667. PubMed ID: 30753598
    [Abstract] [Full Text] [Related]

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 01; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 5. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR, Martin FJ, Spirk D.
    Atherosclerosis; 2018 Oct 01; 277():282-288. PubMed ID: 30270060
    [Abstract] [Full Text] [Related]

  • 6. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M, Watts GF, Tybjærg-Hansen A, Nordestgaard BG.
    Eur Heart J; 2016 May 01; 37(17):1384-94. PubMed ID: 26908947
    [Abstract] [Full Text] [Related]

  • 7. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT, Dissanayake S, Fong JCW, Lin MX, Chan EZL, Tang JI, Lee CW, Ong HY, Sum CF, Lim SC, Tavintharan S.
    Atherosclerosis; 2018 Feb 01; 269():106-116. PubMed ID: 29353225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
    Björnsson E, Thorgeirsson G, Helgadóttir A, Thorleifsson G, Sveinbjörnsson G, Kristmundsdóttir S, Jónsson H, Jónasdóttir A, Jónasdóttir Á, Sigurðsson Á, Guðnason T, Ólafsson Í, Sigurðsson EL, Sigurðardóttir Ó, Viðarsson B, Baldvinsson M, Bjarnason R, Danielsen R, Matthíasson SE, Thórarinsson BL, Grétarsdóttir S, Steinthórsdóttir V, Halldórsson BV, Andersen K, Arnar DO, Jónsdóttir I, Guðbjartsson DF, Hólm H, Thorsteinsdóttir U, Sulem P, Stefánsson K.
    Arterioscler Thromb Vasc Biol; 2021 Oct 01; 41(10):2616-2628. PubMed ID: 34407635
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
    Khera AV, Won HH, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S, Kathiresan S.
    J Am Coll Cardiol; 2016 Jun 07; 67(22):2578-89. PubMed ID: 27050191
    [Abstract] [Full Text] [Related]

  • 11. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
    Lee C, Cui Y, Song J, Li S, Zhang F, Wu M, Li L, Hu D, Chen H.
    Lipids Health Dis; 2019 Apr 11; 18(1):95. PubMed ID: 30971288
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I, Real JT, Martinez-Hervas S, Chaves FJ, Blesa S, Garcia-Garcia AB, Millan E, Ascaso JF, Carmena R.
    Transl Res; 2008 Mar 11; 151(3):162-7. PubMed ID: 18279815
    [Abstract] [Full Text] [Related]

  • 13. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P, Gentile M, Marotta G, Iannuzzi A, Sodano M, De Simone B, Jossa F, Iannuzzo G, Giacobbe C, Di Taranto MD, Fortunato G.
    Eur J Prev Cardiol; 2017 Jul 11; 24(10):1051-1059. PubMed ID: 28353356
    [Abstract] [Full Text] [Related]

  • 14. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM, Civeira F, Stef M, Perez-Calahorra S, Almagro F, Plana N, Novoa FJ, Sáenz-Aranzubía P, Mosquera D, Soler C, Fuentes FJ, Brito-Casillas Y, Real JT, Blanco-Vaca F, Ascaso JF, Pocovi M.
    Circ Cardiovasc Genet; 2016 Dec 11; 9(6):504-510. PubMed ID: 27784735
    [Abstract] [Full Text] [Related]

  • 15. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L, Alonso R, Mata N, Saltijeral A, Muñiz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andrés R, Zambón D, Galiana J, Piedecausa M, Aguado R, Mosquera D, Vidal JI, Ruiz E, Manjón L, Mauri M, Padró T, Miramontes JP, Mata P, SAFEHEART Investigators.
    Arterioscler Thromb Vasc Biol; 2016 Sep 11; 36(9):2004-10. PubMed ID: 27444203
    [Abstract] [Full Text] [Related]

  • 16. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Bourbon M, Alves AC, Alonso R, Mata N, Aguiar P, Padró T, Mata P.
    Atherosclerosis; 2017 Jul 11; 262():8-13. PubMed ID: 28475941
    [Abstract] [Full Text] [Related]

  • 17. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T, Kassner U, Wühle-Demuth M, Salewsky B, Rosada A, Zemojtel T, Hopfenmüller W, Isermann B, Borucki K, Heigl F, Laufs U, Wagner S, Kleber ME, Binner P, März W, Steinhagen-Thiessen E, Demuth I.
    Atherosclerosis; 2016 Oct 11; 253():88-93. PubMed ID: 27596133
    [Abstract] [Full Text] [Related]

  • 18. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J.
    BMC Med Genet; 2015 Sep 28; 16():86. PubMed ID: 26415676
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K, Whatley SD, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta DB, McDowell IF.
    Atherosclerosis; 2015 May 28; 240(1):190-6. PubMed ID: 25797312
    [Abstract] [Full Text] [Related]

  • 20. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L, Freiberger T, Zapletalová P, Soška V, Ravčuková B, Fajkusová L.
    Atherosclerosis; 2012 Aug 28; 223(2):401-8. PubMed ID: 22698793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.